Japanese study of tofogliflozin with type 2 diabetes mellitus patients in an observational study of the elderly (J‐STEP/EL): A 12‐week interim analysis

AIMS/INTRODUCTION: Sodium‐glucose co‐transporter 2 inhibitors are a promising treatment for type 2 diabetes mellitus, but are associated with concerns about specific adverse drug reactions. We carried out a 1‐year post‐marketing surveillance of tofogliflozin, a novel agent in this class, in Japanese...

Descripción completa

Detalles Bibliográficos
Autores principales: Utsunomiya, Kazunori, Shimmoto, Naoki, Senda, Masayuki, Kurihara, Yuji, Gunji, Ryoji, Kameda, Hiroyuki, Tamura, Masahiro, Mihara, Hanako, Kaku, Kohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009139/
https://www.ncbi.nlm.nih.gov/pubmed/27181254
http://dx.doi.org/10.1111/jdi.12513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009139/
https://www.ncbi.nlm.nih.gov/pubmed/27181254
http://dx.doi.org/10.1111/jdi.12513

Ejemplares similares